Neurocrine Biosciences, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Rok finansowy 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 17 15 41 18 139 85 124 39 1 4 3 34 77 53 3 0 20 15 162 451 788 1,046 1,134 1,489 1,887 2,355
Przychód Δ r/r 0.0% -13.2% 182.7% -56.2% 670.7% -38.8% 45.5% -68.3% -96.9% 224.8% -25.7% 1034.5% 131.1% -31.4% -94.5% -100.0% inf% -24.1% 977.5% 179.2% 74.7% 32.7% 8.4% 31.3% 26.8% 24.8%
Marża brutto 112.5% 115.1% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 100.0% 100.0% 99.2% 98.9% 99.1% 99.0% 98.7% 98.4% 97.9% 98.6%
EBIT (mln) -20 -36 -44 -104 -59 -52 -25 -113 -212 -87 -54 -14 34 1 -50 -64 -94 -147 -131 37 219 319 197 249 251 570
EBIT Δ r/r 0.0% 78.9% 23.3% 136.1% -43.3% -11.0% -52.1% 352.0% 87.3% -58.9% -38.5% -74.4% -347.2% -95.7% -3530.8% 29.7% 46.3% 56.4% -10.9% -128.1% 494.0% 45.5% -38.3% 26.5% 0.8% 127.4%
EBIT (%) -118.5% -244.0% -106.4% -574.2% -42.3% -61.4% -20.2% -288.8% -17340.0% -2196.2% -1817.5% -41.0% 43.8% 2.7% -1701.9% 0.0% -476.5% -982.5% -81.3% 8.2% 27.8% 30.5% 17.4% 16.7% 13.3% 24.2%
Koszty finansowe (mln) 0 0 0 -0 -1 -2 -4 -4 -4 -7 -7 -7 0 0 0 0 0 0 20 31 32 33 26 7 5 0
EBITDA (mln) -18 -34 -42 -101 -73 -45 -15 -103 -109 -66 -44 -12 30 -2 -53 -68 -99 -154 -131 37 227 328 208 249 416 610
EBITDA(%) -107.1% -236.2% -101.0% -558.2% -52.6% -53.0% -12.1% -261.9% -8892.0% -1650.7% -1501.3% -36.7% 39.3% -4.0% -1824.3% 0.0% -503.1% -1024.3% -81.3% 8.2% 28.8% 31.3% 18.3% 16.7% 22.0% 25.9%
Podatek (mln) -3 0 0 -9 0 0 0 0 -5 1 0 0 -4 -4 -4 -5 -6 -8 17 1 10 -301 12 59 82 145
Zysk Netto (mln) -17 -29 -37 -95 -30 -46 -22 -107 -207 -89 -51 -8 38 5 -46 -61 -89 -141 -143 21 37 407 90 154 250 341
Zysk netto Δ r/r 0.0% 71.5% 28.1% 156.1% -68.0% 51.3% -51.5% 383.1% 93.4% -57.3% -42.4% -84.4% -571.5% -86.6% -1017.2% 31.4% 46.9% 58.7% 1.0% -114.8% 75.3% 1000.8% -78.0% 72.4% 61.6% 36.7%
Zysk netto (%) -100.0% -197.5% -89.5% -523.9% -21.8% -53.7% -17.9% -273.2% -16936.2% -2229.3% -1728.3% -23.8% 48.5% 9.5% -1579.0% 0.0% -449.8% -940.6% -88.2% 4.7% 4.7% 38.9% 7.9% 10.4% 13.2% 14.5%
EPS -0.88 -1.3 -1.42 -3.1 -0.93 -1.26 -0.6 -2.84 -5.45 -2.3 -1.3 -0.15 0.68 0.0766 -0.69 -0.81 -1.05 -1.63 -1.62 0.22 0.4 4.37 0.95 1.61 2.56 3.4
EPS (rozwodnione) -0.88 -1.3 -1.42 -3.1 -0.93 -1.26 -0.58 -2.84 -5.45 -2.3 -1.3 -0.15 0.67 0.0751 -0.69 -0.81 -1.05 -1.63 -1.62 0.22 0.39 4.16 0.92 1.56 2.47 3.29
Ilośc akcji (mln) 19 22 26 30 32 36 37 38 38 38 39 53 55 66 67 75 84 87 88 95 92 93 95 96 98 100
Ważona ilośc akcji (mln) 19 22 26 30 32 36 38 38 38 38 39 53 56 67 67 75 84 87 88 95 96 98 98 99 101 104
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD